Factors predicting recurrent endometrial cancer. - Wikidata - awgldk - TriplyDB

Factors predicting recurrent endometrial cancer.

Factors predicting recurrent endometrial cancer.

http://www.wikidata.org/entity/Q37703894

about

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.

P2860

Q47713155-45951412-5BC5-4AFD-B6C2-2F8349846603

P2860

Factors predicting recurrent endometrial cancer.

http://www.wikidata.org/entity/Q37703894

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Factors predicting recurrent endometrial cancer.

@en

Factors predicting recurrent endometrial cancer.

@nl

type

label

Factors predicting recurrent endometrial cancer.

@en

Factors predicting recurrent endometrial cancer.

@nl

prefLabel

Factors predicting recurrent endometrial cancer.

@en

Factors predicting recurrent endometrial cancer.

@nl

P1433

Q37703894-A9AAAEDC-5C43-417B-BB16-BCF0C296CF85

P1476

Q37703894-DF526CAB-64F6-4A73-BFEA-1AB8279869DC

P2093

Q37703894-3C9D50F7-A853-4AB8-8C45-102C2E7D9E79

Q37703894-5998A233-A647-491C-A3FF-0D8857C9728C

P2860

Q37703894-1B32C9FF-B4A4-4421-B9A5-4273D47BF6A6

Q37703894-3B9226A4-7FA2-49A6-B6FD-DCF21A2FF04D

Q37703894-5059DE0B-06F7-40D2-9412-283EB08996E8

Q37703894-505E8CE1-76E1-419E-97EF-25EB01000DE9

Q37703894-564EE7A5-2B0E-4E0D-842D-FE965D7FF1F9

Q37703894-57E27E5E-FDBE-4B51-A024-9B1C6FA1F94B

Q37703894-5CD2468D-9A59-478C-9DB6-FF564E07262E

Q37703894-76DCD5A0-3932-4A0B-87E6-8AB53AB2A691

Q37703894-9148445A-3A7E-409F-82E4-4C6BF1432C7C

Q37703894-99AD37F4-1F3B-4D47-A087-E591C5180052

P304

Q37703894-6059C597-E692-41BA-9D62-F276D612361B

P31

Q37703894-58384F02-21EF-4274-9F6B-2715BDA2944E

P433

Q37703894-8B46B9A7-7FD1-4E52-AA1A-A2FFAC9E0852

P478

Q37703894-04C21479-3F72-49A9-9471-34B3E9FD97B1

P577

Q37703894-49266561-058D-49F7-911C-1AE83A8B8521

P698

Q37703894-4E5237C3-8E0B-478B-A157-99C467B65E58

P932

Q37703894-95BFACAA-D5D5-46A4-B005-5F3F2ED11F8D

P1433

Facts, Views & Vision in ObGyn

P1476

Factors predicting recurrent endometrial cancer.

@en

P2093

A N J Huijgens

http://www.w3.org/2001/XMLSchema#string

H J M M Mertens

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Follow-up after primary therapy for endometrial cancer: a systematic review.

Progesterone: the ultimate endometrial tumor suppressor.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Multivariate survival analysis of the patients with recurrent endometrial cancer

Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis.

Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.

Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.

Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.

P304

179-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24753943

http://www.w3.org/2001/XMLSchema#string

P932

3987371

http://www.w3.org/2001/XMLSchema#string